OOIR: Observatory of International Research

Papers

(The TQCC of Best Practice & Research Clinical Endocrinology & Metabolism is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Editorial Board	152
Editorial Board	92
Growth hormone replacement in adults with cured acromegaly: Efficacy and safety	74
Editorial Board	69
Recent progress in molecular classification of phaeochromocytoma and paraganglioma	64
Treatment of acromegaly with the nonpeptide, highly selective somatostatin receptor type 2 agonist paltusotine	62
Gonadectomy in individuals with a difference of sex development – For whom, when, why, and why not?	57
Surgery for prolactinoma	56
Thiazide-induced hyponatremia	54
The role of androgens in transgender medicine	45
Sexual health and contraception in the menopause journey	44
Polygenic risk scores for dyslipidemia and atherosclerotic cardiovascular disease: Progress toward clinical implementation	42
Coronavirus disease 2019 and vitamin D	39
Editorial Board	36
Impulse control disorders and dopamine agonists	35
Editorial Board	34
Cardiometabolic outcomes of early onset hypogonadism in males	34
Remnant lipoprotein particles and cardiovascular disease risk	33
Haematological actions of androgens	31
Optimal surgical approach for digestive neuroendocrine neoplasia primaries: Oncological benefits versus short and long-term complications	31
Radioiodine therapy in the different stages of differentiated thyroid cancer	27
Medullary thyroid cancer - An update	27
Editorial Board	27
Non-oestrogen-based and complementary therapies for menopause	26
Acquired disorders of phosphaturia: Beyond tumor-induced osteomalacia	25

Metabolic complications and their mechanisms in patients with craniopharyngioma	25
Pathogenic role of Th17 cells in autoimmune thyroid disease and their underlying mechanisms	25
Safety of long-term use of daily and long-acting growth hormone in growth hormone-deficient adults on cancer risk	25
Epidemiology and risk factors for hypopituitarism due to traumatic brain injury	24
Approach to patients with elevated low-density lipoprotein cholesterol levels	23
Molecular basis of symptomatic sporadic primary hyperparathyroidism: New frontiers in pathogenesis	23
Editorial Board	22
Pathophysiology and diagnosis of neuroendocrine abnormalities in patients with traumatic brain injury	22
Best practice and research clinical endocrinology and metabolism issue on phaeochromocytomas and paragangliomas	22
Editorial Board	22
Pathophysiology of thyroid-associated orbitopathy	22
History of androgens and androgen action	21
Best Practice and Research Clinical Endocrinology and Metabolism focusing on Growth Hormone Deficiency in Adults – New Perspectives	20
Safety of androgen therapy in men with prostate cancer	20
Personalized management for phaeochromocytomas and paragangliomas in Latin America: A genetic perspective	20
Hyponatraemic encephalopathy	19
Localization in primary hyperparathyroidism	19
Editorial Board	19
Diagnosis and treatment of hypernatremia	18
Recent advances in algorithms predicting hemodynamic instability undergoing surgery for phaeochromocytoma and paraganglioma	18
Editorial Board	18
Genotype-phenotype correlations in Graves’ disease	17
Post cancer care in women with an increased risk of malignancy or previous malignancy: The use of hormone replacement therapy and alternative treatments	17
Hyponatremia and bone pathophysiology: An integrated preclinical and clinical perspective	17
Surgical outcomes in patients with acromegaly: Microscopic vs. endoscopic transsphenoidal surgery	16
Diagnostic algorithm of hyponatremia	16
Editorial Board	15
Preconception use of GLP-1 and GLP-1/GIP receptor agonists for obesity treatment	15
Type 5 diabetes: A disorder associated with undernutrition: The epidemiology, pathogenesis, clinical features and differential diagnosis	15
Preface	15
Mortality in craniopharyngiomas: Data from the last two decades	15
Best practice & research clinical endocrinology & metabolism focusing on the menopause – Diagnostic and therapeutic strategies	15
Chemokines in thyroid autoimmunity	14
Care quality improvement in differences of sex development	14
Editorial Board	14
COVID-induced thyroid autoimmunity	14
The options for delayed surgery – Is there evidence available for delayed genitoplasty in differences/disorders of sex development?	14
Anaplastic thyroid cancer: An update	14
Hormone replacement in disorders of sex development, and long-term effects	14
“Micromegaly”: Acromegaly with apparently normal GH, an entity on its own?	14
Preface	13
Ectopic craniopharyngiomas	13
The epidemiology of disorders of sex development	12
Strategies for improving the knowledge of patients and carers	12
Best practice & research clinical endocrinology & metabolism prolactinoma	12
The interplay between thyrotropic axis, neurological complications, and rehabilitation outcomes in patients with traumatic brain injury	12
Outcomes of pregnancies complicated by type 2 diabetes	12
Addressing the social determinants of adverse outcomes in pregestational diabetes	12
Genetic endocrine tumours focusing on pituitary tumours	12